Dairy, calcium, Vitamin D and ovarian cancer risk in African-American women

British Journal of Cancer

Volumn 115, Issue 9, 2016, Pages 1122-1130

  Qin, Bo ^a   Moorman, Patricia G ^b   Alberg, Anthony J ^c   Barnholtz Sloan, Jill S ^d   Bondy, Melissa ^e   Cote, Michele L ^f   Funkhouser, Ellen ^g   Peters, Edward S ^h   Schwartz, Ann G ^f   Terry, Paul ⁱ   Schildkraut, Joellen M ^j   Bandera, Elisa V ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g University of Alabama at Birmingham   (United States)

^h LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

ⁱ UNIVERSITY OF TENNESSEE   (United States)

^j UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

African American; calcium; dairy; lactose; ovarian cancer; Vitamin D

Indexed keywords

CALCIUM; LACTOSE; VITAMIN D; CALCIUM INTAKE;

ADULT; AFRICAN AMERICAN; ARTICLE; CALCIUM INTAKE; CANCER RISK; CONTROLLED STUDY; DAIRY PRODUCT; DIETARY INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MILK; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK REDUCTION; SUMMER; SUN EXPOSURE; VITAMIN INTAKE; ADMINISTRATION AND DOSAGE; AGED; BLOOD; CASE CONTROL STUDY; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; MORTALITY; NUTRITION; OVARY TUMOR; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGED; CALCIUM, DIETARY; CASE-CONTROL STUDIES; DAIRY PRODUCTS; FEMALE; HUMANS; MIDDLE AGED; NUTRITION SURVEYS; OVARIAN NEOPLASMS; RISK FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84988423199     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.289     Document Type: Article

References (55)

1. Adams JS, Clemens TL, Parrish JA, Holick MF. (1982). Vitamin-D Synthesis and metabolism after ultraviolet irradiation of normal and vitamin-Ddeficient subjects. N Engl J Med 306(12): 722-725
2. Barainca P, Rhodes D, Clemens J, Moshfegh A. (2014). Vitamin D: intake of Americans from diet and supplements (632.10). FASEB J 28(Suppl 1
3. Berek JS, Friedlander ML, Robert C, Bast J. (2010). Ovarian Cancer. In Holland-Frei Cancer Medicine, Kufe DW, Iii EF, Holland JF et al. (eds) 8th edn, pp 1344-1375. People's Medical Publishing House-USA: Shelton, CT, USA
4. Bertone ER, Rosner BA, Hunter DJ, Stampfer MJ, Speizer FE, Colditz GA, Willett WC, Hankinson SE. (2002). Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol 156(1): 22-31
5. Bidoli E, Vecchia CL, Talamini R, Negri E, Parpinel M, Conti E, Montella M, Carbone A, Franceschi S. (2001). Micronutrients and ovarian cancer: a case-control study in Italy. Ann Oncol 12(11): 1589-1593
6. Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G. (2006). Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 9(01): 84-93
7. Bowman SA, Friday JE, Moshfegh AJ. (2008). MyPyramid Equivalents Database, 2.0 for USDA survey foods, 2003-2004: documentation and user guide. Food Surveys Research Group Beltsville Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture: Beltsville, MD, USA
8. Calvo MS, Whiting SJ, Barton CN. (2005). Vitamin D intake: a global perspective of current status. J Nutr 135(2): 310-316
9. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL. (2007). Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 165(7): 802-813
10. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Pietinen P, Potter JD, Rohan TE, Terry P, Toniolo P, Virtanen MJ, Willett WC, Wolk A, Wu K, Yaun SS, Zeleniuch-Jacquotte A, Hunter DJ. (2004). Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96(13): 1015-1022
11. Cook LS, Neilson HK, Lorenzetti DL, Lee RC. (2010) A systematic literature review of vitamin D and ovarian cancer. Am J Obstet Gynecol 203(170): e1-e8
12. Cramer DW. (1989). Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 130(5): 904-910
13. Cramer DW, Willett WC, Bell DA, Ng WG, Harlow BL, Welch WR, Scully RE, Knapp RC. (1989). Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 2(8654): 66-71
14. Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willett WC, Hankinson SE. (2004) A prospective study of dietary lactose and ovarian cancer. Int J Cancer 110(2): 271-277
15. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. (2014). The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14(5): 342-357
16. Fleet JC, Desmet M, Johnson R, Li Y. (2012). Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441(1): 61-76
17. Fulgoni 3rd V, Nicholls J, Reed A, Buckley R, Kafer K, Huth P, DiRienzo D, Miller GD. (2007). Dairy consumption and related nutrient intake in African-American adults and children in the United States: continuing survey of food intakes by individuals 1994-1996, 1998, and the National Health And Nutrition Examination Survey 1999-2000. J Am Diet Assoc 107(2): 256-264
18. Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, Buring JE, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Jacobs Jr. DR, Koushik A, Lacey Jr. JV, Larsson SC, Leitzmann M, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Schouten LJ, Shore R, Smit E, Wolk A, Zhang SM, Smith-Warner SA. (2006). Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 15(2): 364-372
19. Goff BA, Mandel L, Muntz HG, Melancon CH. (2000). Ovarian carcinoma diagnosis. Cancer 89(10): 2068-2075
20. Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AM, Terada K, Wilkens LR, Murphy S, Hankin JH. (2002). Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156(2): 148-157
21. Grant WB. (2012). Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 32(1): 223-236
22. Hall H, Rogers J. (1998). Sun protection behaviors among African Americans. Ethn Dis 9(1): 126-131
23. Holick MF. (2011). Vitamin D: a d-lightful solution for health. J Investig Med 59(6): 872-880
24. Holschneider CH, Berek JS. (2000). Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19(1): 3-10
25. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. (2015). SEER Cancer Statistics Review, 1975-2012. National Cancer Institute Bethesda: MD, USA
26. Hoy MK, Goldman JD. (2014). Calcium intake of the US population, What We Eat in America, NHANES 2009-2010. Food Surveys Research Group: Dietary Data Brief No. 13
27. Kant AK, Graubard BI, Kumanyika SK. (2007). Trends in black-white differentials in dietary intakes of US adults, 1971-2002. Am J Prev Med 32(4): 264-272
28. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. (1981). Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304(17): 994-998
29. Kelemen LE, Kobel M. (2011). Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma. Lancet Oncol 12(11): 1071-1080
30. Koralek DO, Bertone-Johnson ER, Leitzmann MF, Sturgeon SR, Lacey Jr. JV, Schairer C, Schatzkin A. (2006). Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 56(1): 22-30
31. Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, Sellers TA. (1999). Prospective study of diet and ovarian cancer. Am J Epidemiol 149(1): 21-31
32. Larsson SC, Bergkvist L, Wolk A. (2004). Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 80(5): 1353-1357
33. Larsson SC, Orsini N, Wolk A. (2006). Milk, milk products and lactose intake and ovarian cancer risk: a meta-Analysis of epidemiological studies. Int J Cancer 118(2): 431-441
34. Liu G, Hale GE, Hughes CL. (2000). Galactose metabolism and ovarian toxicity. Reprod Toxicol 14(5): 377-384
35. Mares-Perlman JA, Klein B, Klein R, Ritter LL, Fisher MR, Freudenheim JL. (1993) A diet history questionnaire ranks nutrient intakes in middle-Aged and older men and women similarly to multiple food records. J Nutr 123(3): 489-501
36. Merritt MA, Cramer DW, Vitonis AF, Titus LJ, Terry KL. (2013). Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes. Int J Cancer 132(5): 1114-1124
37. Moorman PG, Palmieri RT, Akushevich L, Berchuck A, Schildkraut JM. (2009). Ovarian cancer risk factors in African-American and white women. Am J Epidemiol 170(5): 598-606
38. NASA Earthdata. (2016). Available at http://giovanni.sci.gsfc.nasa.gov/giovanni/ (accessed on 21 February 2016
39. Pan SY, Ugnat AM, Mao Y, Wen SW, Johnson KC. (2004) A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13(9): 1521-1527
40. Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM, Bandera EV. (2016). Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women. Br J Nutr 115(4): 694-702
41. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1): 53-58
42. Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, Escudero-De los Rios P, Hernandez-Avila M. (2002). Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 63(2): 151-157
43. Schildkraut JM, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters E, Schwartz AG, Terry P. (2014) A multicenter population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES). BMC Cancer 14(1): 688
44. Sergeev IN. (2004). Calcium as a mediator of 1, 25-dihydroxyvitamin D3-induced apoptosis. J Steroid Biochem Mol Biol 89-90: 419-425
45. Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, Hall K, Hui SL, Lupton J, Mennella J, Miller NJ, Osganian SK, Sellmeyer DE, Wolf MA. (2010). National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Int Med 152(12): 792-796
46. Tyfield L, Reichardt J, Fridovich-Keil J, Croke DT, Elsas 2nd LJ, Strobl W, Kozak L, Coskun T, Novelli G, Okano Y, Zekanowski C, Shin Y, Boleda MD. (1999). Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 13(6): 417-430
47. Tzonou A, Hsieh CC, Polychronopoulou A, Kaprinis G, Toupadaki N, Trichopoulou A, Karakatsani A, Trichopoulos D. (1993). Diet and ovarian cancer: a case-control study in Greece. Int J Cancer 55(3): 411-414
48. US Department of Agriculture ARS, Nutrient Data Laboratory. (2015). USDA National Nutrient Database for Standard Reference, Release 28. Version Current: September 2015. Available at https://www.ars.usda.gov/northeast-Area/beltsville-md/beltsville-human-nutrition-research-center/nutrient-data-laboratory/docs/usda-national-nutrient-database-forstandard-reference/ (accessed on 04 January 2016
49. van der Rhee H, Coebergh JW, de Vries E. (2013). Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer 49(6): 1422-1436
50. Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. (2001). Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol 83(3): 466-471
51. Webb AR. (2006). Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 92(1): 17-25
52. Webb PM, Bain CJ, Purdie DM, Harvey PW, Green A. (1998). Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 9(6): 637-644
53. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. (2011). Meta-Analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol 121(2): 369-375
54. Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV, Bai W. (2005). Growth Suppression of Ovarian Cancer Xenografts in Nude Mice by Vitamin D Analogue EB1089. Clin Cancer Res 11(1): 323-328
55. Zheng W, Danforth KN, Tworoger SS, Goodman MT, Arslan AA, Patel AV, McCullough ML, Weinstein SJ, Kolonel LN, Purdue MP, Shu XO, Snyder K, Steplowski E, Visvanathan K, Yu K, Zeleniuch-Jacquotte A, Gao YT, Hankinson SE, Harvey C, Hayes RB, Henderson BE, Horst RL, Helzlsouer KJ. (2010). Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172(1): 70-80